{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-097776","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.589621+00:00","generated_at":"2026-06-03T22:04:10.936092+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CareDx appoints John W. Hanna as President and CEO effective April 15, 2024","bullets":["John Hanna appointed CEO and Class III director, effective April 15, 2024.","Annual base salary of $675,000; eligible for annual bonus up to 100% of salary.","Received inducement options and RSUs each valued at $4M, vesting over four years.","Previously CEO of Apton Biosystems and CCO at Veracyte for ten years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-097776","json":"https://secwatch.observer/filing/0001193125-24-097776.json","markdown":"https://secwatch.observer/filing/0001193125-24-097776.md","text":"https://secwatch.observer/filing/0001193125-24-097776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/d822701d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:04:10.936092+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e96010b45","claim":"John W. Hanna was appointed as Class III director at CareDx, Inc..","evidence_excerpt":"The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"},{"claim_id":"4191370b1b","claim":"John W. Hanna was appointed as President and Chief Executive Officer at CareDx, Inc..","evidence_excerpt":"The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}